Discovery of Pyrazolo[1,5-<i>a</i>]pyridine Derivatives as Potent and Selective PI3Kγ/δ Inhibitors

PI3Kγ and PI3Kδ plays critical roles in exerting immunosuppression by targeting regulatory T cells and myeloid cells. Dual inhibition of PI3Kγ and PI3Kδ has emerged as a novel therapeutic strategy for cancer immunotherapy. We herein report a series of pyrazolopyridine derivatives with distinct scaffolds as potent and selective dual inhibitors of PI3Kγ and PI3Kδ. Among them, <b>20e</b> (<b>IHMT-PI3K-315</b>) displays an IC<sub>50</sub> value of 4.0 and 9.1 nM against PI3Kγ and PI3Kδ respectively in biochemical assays. Meanwhile, it potently inhibits PI3Kγ and PI3Kδ-mediated phosphorylation of AKT S473 with EC<sub>50</sub> values of 0.028 and 0.013 μM in cellular assays. In addition, <b>20e</b> exhibits a favorable selectivity profile in protein kinases at 1 μM. In bone marrow-derived macrophages (BMDM), <b>20e</b> can repolarize the M2 phenotype to the M1 phenotype. In vivo, <b>20e</b> demonstrates acceptable pharmacokinetic properties and suppresses tumor growth in a MC38 syngeneic mouse model.

Authors

Institutions

Publication Details

Journal
Journal of Medicinal Chemistry
Published
2024-08-20
DOI
https://doi.org/10.1021/acs.jmedchem.4c00817
Citations
4
Primary Topic
PI3K/AKT/mTOR signaling in cancer
Type
article
Field-Weighted Citation Impact
0.94

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Discovery of Pyrazolo[1,5-a]pyridine Derivatives as Potent and Selective PI3Kγ/δ Inhibitors

Maoqing Deng, Xinyu Yuan, Aoli Wang, Xiaofei Liang et al.
4 citations
Journal of Medicinal Chemistry
PI3K/AKT/mTOR signaling in cancer
0.94
article

Discovery of Pyrazolo[1,5-a]pyridine Derivatives as Potent and Selective PI3Kγ/δ Inhibitors

Maoqing Deng, Xinyu Yuan, Aoli Wang, Xiaofei Liang, Li Wang, Beilei Wang, Chun Wang, Qingwang Liu, Lijuan Shen, Fengming Zou, Ziping Qi, Jing Liu
article en
4 citations

Abstract

PI3Kγ and PI3Kδ plays critical roles in exerting immunosuppression by targeting regulatory T cells and myeloid cells. Dual inhibition of PI3Kγ and PI3Kδ has emerged as a novel therapeutic strategy for cancer immunotherapy. We herein report a series of pyrazolopyridine derivatives with distinct scaffolds as potent and selective dual inhibitors of PI3Kγ and PI3Kδ. Among them, <b>20e</b> (<b>IHMT-PI3K-315</b>) displays an IC<sub>50</sub> value of 4.0 and 9.1 nM against PI3Kγ and PI3Kδ respectively in biochemical assays. Meanwhile, it potently inhibits PI3Kγ and PI3Kδ-mediated phosphorylation of AKT S473 with EC<sub>50</sub> values of 0.028 and 0.013 μM in cellular assays. In addition, <b>20e</b> exhibits a favorable selectivity profile in protein kinases at 1 μM. In bone marrow-derived macrophages (BMDM), <b>20e</b> can repolarize the M2 phenotype to the M1 phenotype. In vivo, <b>20e</b> demonstrates acceptable pharmacokinetic properties and suppresses tumor growth in a MC38 syngeneic mouse model.

Journal of Medicinal ChemistryVol. 67(17)
University of Science and Technology of China (CN), Chinese Academy of Sciences (CN), Hefei Institutes of Physical Science (CN)
National Natural Science Foundation of China, Youth Innovation Promotion Association of the Chinese Academy of Sciences, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Anhui Provincial Key Research and Development Plan, Major Science and Technology Projects in Anhui Province
Good health and well-being
Openalex Percentile: Top 26%
PI3K/AKT/mTOR signaling in cancer
0.94
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.